Skip to content
Professionals
Services
Insights
Community
About
Offices
Careers
Professionals
Services
Insights
Community
About
Offices
Careers
Home
/
Insights
/
Approval Biosimilar Notice ...
Share
+
PDF
08/03/2016 | Managing Intellectual Property Blog
Brian L. Klock
Approval Biosimilar Notice Implicates Millions
1
min
The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
View Full PDF
Related Services
Practices
Biotechnology and Biologics
Intellectual Property
Intellectual Property Litigation
Related Insights
David Barr Co-Authors the 2024 Edition of the PLI Treatise
David Barr Co-Authors the 2024 Edition of the PLI Treatise
July 24, 2024
1min
FDA Approves Second Soliris® (eculizumab) Interchangeable Biosimilar – Samsung Bioepis’s Epysqli® (eculizumab-aagh)
FDA Approves Second Soliris® (eculizumab) Interchangeable Biosimilar – Samsung Bioepis’s Epysqli® (eculizumab-aagh)
July 24, 2024
2min
Understanding the Work Made for Hire Doctrine in Copyright Law – Part 2
Understanding the Work Made for Hire Doctrine in Copyright Law – Part 2
July 16, 2024
3min
View More
Recent News
In Conversation: Nearly Two Years On, Paul Battista and Michael Joblove Assess the Impact of Venable’s Expansion into Florida
In Conversation: Nearly Two Years On, Paul Battista and Michael Joblove Assess the Impact of Venable’s Expansion into Florida
July 24, 2024
5min
Noise in the Basement to Take Stage at Law Rocks DC
Noise in the Basement to Take Stage at Law Rocks DC
July 23, 2024
2min
Sean Franzblau Joins Venable’s Investigations and White Collar Defense Practice in Chicago
Sean Franzblau Joins Venable’s Investigations and White Collar Defense Practice in Chicago
July 23, 2024
2min
View More